Rachel Perry, Ph.D. is a Postdoctoral Fellow in Medicine/Endocrinology at the Yale University School of Medicine. Rachel's background is in the use of hyperinsulinemic-euglycemic clamps and stable isotope infusions to assess insulin sensitivity, having earned her B.S. in Biomedical Engineering, her Ph.D. (with Distinction) in Cellular & Molecular Physiology, and performed her postdoctoral training in Medicine/Endocrinology, all in the laboratory of Dr. Gerald Shulman. With first-author papers in Nature, Cell, Science, Nature Medicine, Nature Communications, JBC, Cell Metabolism, and AJP-Endocrinology, Rachel's publication record speaks to the depth and breadth of her expertise in metabolic physiology. As Co-Director of Yale's Mouse Metabolic Phenotyping Center Physiology Core, Rachel assists investigators worldwide in performing clamp studies, glucose tolerance tests, and metabolic cage analysis to assess the metabolic phenotypes of their transgenic mice.
Research interests include flux modeling, examining the mechanisms and role of dysregulated substrate flux pathways in driving insulin resistance, type 1 and type 2 diabetes, and the role of hyperinsulinemia and obesity in driving tumor progression.
